Todd Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.1M Buy
282,442
+40,131
+17% +$8.63M 1.26% 24
2026
Q1
$52.7M Buy
242,311
+18,280
+8% +$4.05M 1.03% 37
2025
Q4
$51.2M Sell
224,031
-286
-0.1% -$65.2K 1% 35
2025
Q3
$51.9M Sell
224,317
-4,169
-2% -$849K 1.05% 33
2025
Q2
$42.4M Sell
228,486
-2,365
-1% -$440K 0.91% 45
2025
Q1
$48.4M Buy
230,851
+1,475
+0.6% +$287K 1.14% 27
2024
Q4
$40.8M Buy
229,376
+2,580
+1% +$474K 0.98% 39
2024
Q3
$44.8M Sell
226,796
-172
-0.1% -$32.1K 1.04% 32
2024
Q2
$38.9M Sell
226,968
-2,236
-1% -$370K 0.81% 45
2024
Q1
$41.7M Sell
229,204
-16,646
-7% -$2.87M 0.85% 33
2023
Q4
$38.1M Sell
245,850
-43,417
-15% -$6.33M 0.84% 31
2023
Q3
$43.1M Sell
289,267
-403
-0.1% -$59.2K 1.02% 20
2023
Q2
$39M Sell
289,670
-37,474
-11% -$5.5M 0.91% 28
2023
Q1
$52.1M Buy
327,144
+17,749
+6% +$2.71M 1.26% 10
2022
Q4
$50M Sell
309,395
-728
-0.2% -$112K 1.21% 13
2022
Q3
$41.6M Sell
310,123
-3,017
-1% -$433K 1.16% 16
2022
Q2
$48M Sell
313,140
-29,465
-9% -$4.5M 1.24% 12
2022
Q1
$55.5M Sell
342,605
-4,844
-1% -$704K 1.22% 13
2021
Q4
$47M Sell
347,449
-16,778
-5% -$1.98M 1.01% 23
2021
Q3
$39.3M Sell
364,227
-2,011
-0.5% -$230K 0.9% 28
2021
Q2
$41.3M Buy
366,238
+36,396
+11% +$4.1M 0.93% 25
2021
Q1
$35.7M Sell
329,842
-964
-0.3% -$103K 0.84% 35
2020
Q4
$35.4M Sell
330,806
-116,135
-26% -$11.2M 0.9% 27
2020
Q3
$39.1M Buy
446,941
+142,774
+47% +$13.4M 1.17% 13
2020
Q2
$29.9M Sell
304,167
-26,895
-8% -$2.37M 0.95% 26
2020
Q1
$25.2M Sell
331,062
-41,303
-11% -$3.52M 0.96% 27
2019
Q4
$33M Buy
372,365
+28,434
+8% +$2.36M 0.82% 35
2019
Q3
$26M Sell
343,931
-678
-0.2% -$46.5K 0.71% 46
2019
Q2
$25.1M Buy
344,609
+46,033
+15% +$3.62M 0.69% 51
2019
Q1
$24.1M Buy
298,576
+68,494
+30% +$5.6M 0.68% 54
2018
Q4
$21.2M Buy
230,082
+12,986
+6% +$1.14M 0.68% 47
2018
Q3
$20.5M Sell
217,096
-156,685
-42% -$14.9M 0.56% 65
2018
Q2
$34.6M Sell
373,781
-4,087
-1% -$399K 0.97% 24
2018
Q1
$35.8M Buy
377,868
+145,528
+63% +$16M 0.99% 25
2017
Q4
$22.5M Sell
232,340
-4,080
-2% -$385K 0.61% 62
2017
Q3
$21M Buy
236,420
+222,036
+1,544% +$16.9M 0.58% 68
2017
Q2
$1.04M Buy
14,384
+86
+0.6% +$5.78K 0.03% 185
2017
Q1
$931K Buy
14,298
+296
+2% +$18.6K 0.03% 188
2016
Q4
$877K Sell
14,002
-210
-1% -$12.8K 0.03% 192
2016
Q3
$896K Hold
14,212
0.03% 186
2016
Q2
$880K Sell
14,212
-615
-4% -$37.5K 0.03% 183
2016
Q1
$847K Sell
14,827
-1,967
-12% -$110K 0.03% 189
2015
Q4
$995K Sell
16,794
-6,881
-29% -$396K 0.03% 186
2015
Q3
$1.29M Sell
23,675
-270
-1% -$17.6K 0.04% 180
2015
Q2
$1.61M Sell
23,945
-330
-1% -$21.5K 0.04% 186
2015
Q1
$1.42M Sell
24,275
-15,477
-39% -$935K 0.04% 184
2014
Q4
$2.6M Sell
39,752
-1,418
-3% -$89.4K 0.07% 165
2014
Q3
$2.38M Sell
41,170
-1,021
-2% -$56.7K 0.07% 169
2014
Q2
$2.38M Buy
42,191
+142
+0.3% +$7.45K 0.07% 174
2014
Q1
$2.16M Sell
42,049
-2,037
-5% -$103K 0.06% 154
2013
Q4
$2.33M Buy
44,086
+5,495
+14% +$270K 0.07% 152
2013
Q3
$1.73M Sell
38,591
-1,137
-3% -$50.4K 0.05% 158
2013
Q2
$1.64M Buy
+39,728
New +$1.74M 0.05% 185

Other funds holding ABBV

Todd Asset Management's ABBV Position: Q2 2026 in Review

Todd Asset Management increased its AbbVie (ABBV) stake by 17% in Q2 2026, buying an estimated $8.63M and bringing the position to 282,442 shares worth $71.1M. The position accounts for 1.26% of the portfolio, ranked #24.

Todd Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Todd Asset Management held 282,442 shares of AbbVie worth $71.1M as of Q2 2026.
  • Todd Asset Management bought 40,131 AbbVie shares in Q2 2026, an estimated $8.63M.
  • AbbVie made up 1.26% of Todd Asset Management's portfolio in Q2 2026, its #24 holding.
  • Todd Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Todd Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.